Fernando Cabrera-Bueno

Fernando Cabrera-Bueno

Auto-generated profile, based on publicly available information

Fernando Cabrera-Bueno

UGC del Corazón, Servicio de Cardiología, Hospital Clínico Universitario Virgen de la Victoria de Málaga, IMIBA (Instituto de Investigación Biomédica de Málaga), Universidad de Málaga, Spain

Research Focus & Metrics

Academic Career Length

26Years (2001-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
24 November 2009 in European Heart Journal - Cardiovascular Imaging
Verified
Journal Article
Open access
PDF file
FCFernando Cabrera-Bueno
Fernando Cabrera-Bueno
MMMaria Jose Molina-Mora
Maria Jose Molina-Mora
JAJavier Alzueta
Javier Alzueta
JPJose Pena-Hernandez
Jose Pena-Hernandez
MJManuel Jiménez-Navarro
Manuel Jiménez-Navarro
ETEduardo de Teresa
Eduardo de Teresa
Cardiac resynchronization therapy (CRT) improves survival and quality of life in advanced heart failure (HF). Although mitral regurgitation (MR) reduction has been reported, its presence has been associated with non-response to CRT. This study was undertaken to assess the potential role of significant mitral regurgitation (SMR) persistence after CRT on clinical outcome, major arrhythmic events, and echocardiographic response in the mid-long term. Seventy-six patients (28.9% women, 63 ± 11 years) with dilated cardiomyopathy in advanced HF were included. SMR, defined as regurgitant orifice area ≥0.20 cm 2 , was assessed at baseline and its evolution 6 months after CRT. Clinical outcome (cardiovascular death/HF readmission), major arrhythmic events, and echocardiographic response (reverse remodelling) were recorded on follow-up. Thirty-two patients (42.1%) presented baseline SMR, becoming non-significant in 11 of the 32 patients (34.3%) 6 months after CRT. Its persistence was associated with higher rates of clinical events (46.4 vs. 18.7%, P = 0.011), arrhythmic events (35.7 vs. 14.5%, P = 0.034), and less reverse remodelling (28.5 vs. 83.3%, P < 0.001). CRT can reduce moderate or severe baseline MR to non-significant in one-third of patients. However, its persistence was associated with worse clinical evolution, greater incidence of arrhythmic events, and less reverse remodelling.

1 May 2015 in Cytokine
Verified
Journal Article
Closed access
FCFernando Cabrera-Bueno
Fernando Cabrera-Bueno
CMCarmen Medina-Palomo
Carmen Medina-Palomo
ARAmalio Ruiz-Salas
Amalio Ruiz-Salas
AFAna Flores
Ana Flores
NRNoela Rodriguez-Losada
Noela Rodriguez-Losada
JAJavier Alzueta
Javier Alzueta

15 June 2007 in EP Europace
Verified
Journal Article
Open access
PDF file
FCFernando Cabrera-Bueno
Fernando Cabrera-Bueno
JGJosé Manuel García-Pinilla
José Manuel García-Pinilla
JPJosé Peña-Hernández
José Peña-Hernández
MJManuel Jiménez-Navarro
Manuel Jiménez-Navarro
JDJuan Jose Gomez Doblas
Juan Jose Gomez Doblas
ETEduardo de Teresa-Galván
Eduardo de Teresa-Galván
Aims Cardiac resynchronization therapy (CRT) reduces the degree of functional mitral regurgitation (FMR). However, FMR has also been associated with a lack of clinical response to CRT. We undertook this study to determine whether the presence of FMR influences the reverse remodelling induced by CRT. Methods and results We used Doppler echocardiography to assess 20 patients with dilated cardiomyopathy before and 6 months after undergoing CRT. We evaluated the effect of reverse remodelling (reduction ≥ 10% in end-systolic volume) according to the presence or absence of important FMR, defined as a regurgitant orifice area (ROA) of ≥ 0.20 cm 2 . Of the 20 patients (mean age, 64.7 ± 8.2 years, eight women), 9 had marked FMR (ROA 0.40 ± 0.12 cm 2 ), 6 mild FMR (ROA 0.15 ± 0.02 cm 2 ), and 5 had trivial or no FMR. CRT reduced the presence of mitral regurgitation by 33.3% and induced reverse remodelling in 60% of the patients. A ROA ≥ 0.20 cm 2 was associated with a lack of reverse remodelling, despite presenting similar baseline characteristics and a reduction in asynchrony to the other patients. Reverse remodelling was produced in all the other patients, with a significant reduction in end-systolic volume (41.7 ± 21%; P = 0.003), accompanied by improvement in the ejection fraction ( P = 0.003) and myocardial performance index ( P = 0.027). Conclusion CRT improved FMR, although the baseline presence of important mitral regurgitation, with a ROA ≥ 0.20 cm 2 , in patients undergoing CRT was associated with a lack of response in reverse remodelling.

1 January 2001 in Revista Espanola de Cardiologia
Verified
Journal Article
Closed access
FBFernando Cabrera Bueno
Fernando Cabrera Bueno
JDJuan Jose Gomez Doblas
Juan Jose Gomez Doblas
MRManuel Ruiz Ruiz
Manuel Ruiz Ruiz
MJManuel Jiménez-Navarro
Manuel Jiménez-Navarro
IBIsabel Rodríguez Bailón
Isabel Rodríguez Bailón
EGEduardo de Teresa Galván
Eduardo de Teresa Galván

1 December 2004 in Revista Espanola de Cardiologia
Verified
Journal Article
Closed access
FBFernando Cabrera Bueno
Fernando Cabrera Bueno
IBIsabel Rodríguez Bailón
Isabel Rodríguez Bailón
RSRaúl López Salguero
Raúl López Salguero
JDJuan J Gómez Doblas
Juan J Gómez Doblas
ACAlejandro Isidoro Pérez Cabeza
Alejandro Isidoro Pérez Cabeza
EGEduardo de Teresa Galván
Eduardo de Teresa Galván

24 February 2009 in Echocardiography
Verified
Journal Article
Closed access
PDF file
FCFernando J. Cabrera-Bueno
Fernando J. Cabrera-Bueno
JDJuan Jose Gomez Doblas
Juan Jose Gomez Doblas
JGJose M. Garcia-Pinilla
Jose M. Garcia-Pinilla
AMAngel Montiel-Trujillo
Angel Montiel-Trujillo
MJManuel Jiménez-Navarro
Manuel Jiménez-Navarro
ETEduardo de Teresa-Galván
Eduardo de Teresa-Galván